Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B2 | P37059 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8168711 | 1.00 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL8744051 | 1.00 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL8488891 | 1.00 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL8168705 | 1.00 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL512507 | 0.88 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL6778943 | 0.88 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL513876 | 0.85 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL6768260 | 0.81 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL6774544 | 0.81 | HSD17B2 (1.00) | HSD17B2 | |
| SCHEMBL6768258 | 0.81 | HSD17B2 (1.00) | HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES | 2003-11-06 | — | — | US | disclosed |
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES | 2003-11-06 | — | — | US | disclosed |
| EP-1348696-A1 | Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2003-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | HIF1AN, HIF1A, CLN6 | HSD17B2 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.